Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

535
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
535
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

454
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
454
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

947
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
947

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and methodology of a randomized clinical trial of prolonged daily antibiotic suppression with and without fulguration for uncomplicated recurrent urinary tract infections in women.

medRxiv : the preprint server for health sciences·2026
Same author

Quantitative Analysis of External Urethral Sphincter Stimulation Parameters for Modulating Urinary Output.

bioRxiv : the preprint server for biology·2026
Same author

Urinary Tract Infection (UTI)-free and Recurrent UTI (rUTI)-Free Survivals Following Bladder Electrofulguration in Women With a History of Antibiotic-Refractory rUTI.

Open forum infectious diseases·2026
Same author

Strain level variation in <i>Proteus mirabilis</i> chondroitin sulfate degradation kinetics and regulation by urea.

bioRxiv : the preprint server for biology·2026
Same author

Bladder wall-embedded bacteria associated with increased risk of recurrence after electrofulguration in women with antibiotic-recalcitrant urinary tract infection.

JU open plus·2026
Same author

Inter-observer and Intra-observer Reproducibility for the Determination of Female Urethral Narrowing on Voiding Cystourethrogram: A Retrospective Study.

Cureus·2026

Related Experiment Video

Updated: Apr 8, 2026

Transvaginal Mesh Insertion in the Ovine Model
10:32

Transvaginal Mesh Insertion in the Ovine Model

Published on: July 27, 2017

17.2K

Prolapse Recurrence after Transvaginal Mesh Removal.

Tanner Rawlings1, Rebecca S Lavelle1, Burhan Coskun1

  • 1University of Texas Southwestern Medical Center, Dallas, Texas.

The Journal of Urology
|June 30, 2015
PubMed
Summary

Transvaginal mesh removal for pelvic organ prolapse showed a 12% recurrence rate in the same compartment. Most patients (85%) did not require further prolapse procedures after mesh removal.

Keywords:
device removalpelvic organ prolapserecurrencesurgical meshurinary bladder

More Related Videos

A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation
13:45

A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation

Published on: June 20, 2025

1.1K
Application of a New Mesh Fixation Method in Laparoscopic Incisional Hernia Repair
05:15

Application of a New Mesh Fixation Method in Laparoscopic Incisional Hernia Repair

Published on: December 23, 2022

7.7K

Related Experiment Videos

Last Updated: Apr 8, 2026

Transvaginal Mesh Insertion in the Ovine Model
10:32

Transvaginal Mesh Insertion in the Ovine Model

Published on: July 27, 2017

17.2K
A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation
13:45

A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation

Published on: June 20, 2025

1.1K
Application of a New Mesh Fixation Method in Laparoscopic Incisional Hernia Repair
05:15

Application of a New Mesh Fixation Method in Laparoscopic Incisional Hernia Repair

Published on: December 23, 2022

7.7K

Area of Science:

  • Urogynecology
  • Pelvic Floor Reconstruction
  • Surgical Outcomes

Background:

  • Transvaginal mesh placement has been used for pelvic organ prolapse (POP) repair.
  • Complications necessitate transvaginal mesh removal, but recurrence rates post-removal are not well-defined.

Purpose of the Study:

  • To determine the rate of pelvic organ prolapse recurrence after transvaginal mesh removal.
  • To analyze recurrence in the same compartment versus different compartments.

Main Methods:

  • A retrospective review of a database of women undergoing transvaginal mesh removal with at least 1-year follow-up.
  • Pelvic organ prolapse recurrence defined as > stage 1 on examination or reoperation.
  • Patients categorized into same-compartment recurrence, persistent prolapse, or different-compartment prolapse.

Main Results:

  • Of 52 women meeting criteria, 15% (6/40) experienced recurrence in the same compartment as mesh removal.
  • 23% (12/52) had persistent prolapse, and 6% (3/52) developed prolapse in a different compartment.
  • Most patients (62%) had no recurrent or persistent prolapse at a mean 2.5-year follow-up.

Conclusions:

  • Transvaginal mesh removal can be effective, with a low rate of recurrence in the same compartment (12%).
  • A significant majority (85%) of patients did not require further prolapse surgery after mesh removal.
  • This suggests transvaginal mesh removal is a viable option for managing complications while achieving favorable prolapse outcomes.